STAT

FDA slams Dollar Tree for purchasing drugs from suppliers with checkered safety records

Dollar Tree purchased drugs from foreign companies that failed to follow manufacturing standard, displaying a pattern of serious violations, the FDA said in a warning letter.
Source: Justin Sullivan/Getty Images

Amid growing concerns over the pharmaceutical supply chain, regulators sternly warned the Dollar Tree (DLTR), which runs a vast network of stores serving mostly low-income communities, for selling over-the-counter medicines made by companies that failed to ensure the drugs were safely manufactured and tested.

In a , the Food and Drug Administration noted the retailer purchased medicines

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks